Applied therapeutics reports fourth quarter and year-end 2022 financial results

Progress in three phase 3 trials in areas of high unmet clinical need, including positive sorbitol reduction data from the ongoing phase 3 inspire trial in sorbitol dehydrogenase (sord) deficiency
APLT Ratings Summary
APLT Quant Ranking